GERN : Summary for Geron Corporation - Yahoo Finance

U.S. Markets close in 3 hrs.

Geron Corporation (GERN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.13+0.04 (+1.67%)
As of 12:59PM EDT. Market open.
People also watch
STEMARIAINCYEXELCTIC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.10
Open2.10
Bid2.13 x 6800
Ask2.14 x 3900
Day's Range2.08 - 2.16
52 Week Range1.81 - 3.35
Volume580,935
Avg. Volume1,444,428
Market Cap339.8M
Beta3.32
PE Ratio (TTM)-11.24
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire3 days ago

    Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma

    NEW YORK, NY / ACCESSWIRE / March 20, 2017 / As both Geron and Galena Biopharma show signs of biotech life with their FDA trial advancements, the stocks also have a common problem – how to convince investors ...

  • Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube6 days ago

    Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Geron Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Geron Corp. – Gilead Sciences, Inc., CTI BioPharma Corp., Bio-Techne Corporation, Immunomedics, Inc. and Incyte Corporation (GILD-US, CTIC-US, TECH-US, IMMU-US and INCY-US) that have also reported for this period. ... Read more (Read more...)

  • Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube8 days ago

    Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Geron Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Geron Corp. – Gilead Sciences, Inc., Bio-Techne Corporation, Immunomedics, Inc., CTI BioPharma Corp. and Incyte Corporation (GILD-US, TECH-US, IMMU-US, CTIC-US and INCY-US) that have also reported for this period. ... Read more (Read more...)